Innovating CBT-I for cancer survivors: study protocol for a randomized controlled optimization trial

Authors

  • Emma G. Balkind Massachusetts General Hospital, Boston, MA, United States
  • Kelcie D. Willis Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States
  • Caleb Bolden Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States
  • Alona Muzikansky Massachusetts General Hospital, Boston, MA, United States
  • Mark J. Gorman Massachusetts General Hospital, Boston, MA, United States
  • Amy H. Comander Massachusetts General Hospital, Boston, MA, United States
  • Dana Haggett Massachusetts General Hospital, Boston, MA, United States
  • Lynne Wagner Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States
  • Joe Kossowsky Harvard Medical School, Boston, MA, United States; Boston Children’s Hospital, Boston, MA, United States
  • Elyse R. Park Massachusetts General Hospital, Boston, MA, United States
  • Timur Mukhammadov Massachusetts General Hospital, Boston, MA, United States
  • Tolulope Adewumi Massachusetts General Hospital, Boston, MA, United States
  • Daniel L. Hall Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States

DOI:

https://doi.org/10.18203/2349-3259.ijct20251208

Keywords:

Insomnia, CBT-I, Survivorship, Cancer, Oncology, Optimization, MOST

Abstract

Background: Insomnia is a significant issue in 30-50% of cancer survivors. Our pilot randomized controlled trial of synchronous, virtual cognitive behavioral therapy for insomnia (CBT-I) for cancer survivors suggested that a group format or booster sessions may optimize effects on insomnia and daytime functioning. The goal of this project is to conduct a factorial, randomized controlled trial to optimize synchronous, virtual delivery of CBT-I for cancer survivors.

Methods: We will conduct a 2×2 factorial trial (N=80) to evaluate the optimal combination of two intervention design components: delivery (individual vs. group) and booster sessions (0 vs 3). The primary outcome is change in insomnia severity (insomnia severity index) from T0 (week 0) to T2 (week 8). The secondary outcomes are acute (T0-T1, week 4) and sustained (T0-T3, week 16) changes in insomnia severity, emotional distress, work-related functioning, use of sleep medications, and subjective and objective sleep metrics (measured with sleep diaries and Fitbit). Exploratory aim 1 is to characterize study participation and sleep outcomes among racial and ethnic minority cancer survivors with insomnia. Exploratory aim 2 is to characterize the acceptability of design components using Likert ratings (very low=1 to very high=5, benchmarks=4 or higher) and exit interviews with open-ended responses with probes.

Conclusions: This project will yield multiple deliverables to innovate cancer survivorship care, chiefly an optimized, scalable, virtually delivered intervention that addresses chronic insomnia, one of the most deleterious concerns among the among the steadily increasing number of cancer survivors.

Trial Registration: NCT06181643.

Metrics

Metrics Loading ...

References

American Cancer Society. Cancer facts and figures 2013. American Cancer Society, Atlanta. 2013.

Savard J, Morin CM. Insomnia in the context of cancer: A review of a neglected problem. J Clin Oncol. 2001;19(3):895-908. DOI: https://doi.org/10.1200/JCO.2001.19.3.895

Irwin MR. Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes. Current Psych Rep. 2013;15(11):404. DOI: https://doi.org/10.1007/s11920-013-0404-1

Innominato PF, Focan C, Gorlia T. Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 2009;69(11):4700-4707. DOI: https://doi.org/10.1158/0008-5472.CAN-08-4747

Ancoli-Israel S. Recognition and treatment of sleep disturbances in cancer. J of Clin Oncol. 2009;27(35):5864-6. DOI: https://doi.org/10.1200/JCO.2009.24.5993

Balachandran DD, Faiz S, Bashoura L, Manzullo E. Cancer-related fatigue and sleep disorders. Sleep medicine clinics. 2013;8(2):229-34. DOI: https://doi.org/10.1016/j.jsmc.2013.02.005

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Ann Int Med. 2016;165(2):125-33. DOI: https://doi.org/10.7326/M15-2175

National Institutes of Health. National Institutes of Health state of the science conference statement on manifestations and management of chronic insomnia in adults. Sleep. 2005;28(9):1049-57. DOI: https://doi.org/10.1093/sleep/28.9.1049

Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev. 2006;10(6):419-29. DOI: https://doi.org/10.1016/j.smrv.2006.03.005

Ballesio A, Aquino M, Feige B. The effectiveness of behavioural and cognitive behavioural therapies for insomnia on depressive and fatigue symptoms: A systematic review and network meta-analysis. Sleep Med Rev. 2018;37:114-29. DOI: https://doi.org/10.1016/j.smrv.2017.01.006

Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M. Cognitive behavioral therapy in persons with comorbid insomnia: A meta-analysis. Sleep Med Rev. 2015;23:54-67. DOI: https://doi.org/10.1016/j.smrv.2014.11.007

Straten A, Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018;38:3-16. DOI: https://doi.org/10.1016/j.smrv.2017.02.001

Johnson JA, Rash JA, Campbell TS. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev. 2016;27:20-8. DOI: https://doi.org/10.1016/j.smrv.2015.07.001

Ma Y, Hall DL, Ngo LH, Liu Q, Bain PA, Yeh GY. Efficacy of cognitive behavioral therapy for insomnia in breast cancer: A meta-analysis. Sleep Med Rev. 2021;55:101376. DOI: https://doi.org/10.1016/j.smrv.2020.101376

Squires LR, Rash JA, Fawcett J, Garland SN. Systematic review and meta-analysis of cognitive-behavioural therapy for insomnia on subjective and actigraphy-measured sleep and comorbid symptoms in cancer survivors. Sleep Med Rev. 2022;10:1615. DOI: https://doi.org/10.1016/j.smrv.2022.101615

Goldstein D, Bennett B, Friedlander M, Davenport T, Hickie I, Lloyd A. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer. 2006;6:1-8. DOI: https://doi.org/10.1186/1471-2407-6-240

Savard J, Ivers H, Savard MH. Efficacy of a stepped care approach to deliver cognitive-behavioral therapy for insomnia in cancer patients: A noninferiority randomized controlled trial. Sleep. 2021;44(11):67-9.

Savard J, Ivers H, Savard MH. Efficacy of a stepped care approach to deliver cognitive-behavioral therapy for insomnia in cancer patients: A noninferiority randomized controlled trial. Sleep. 2021;44(11):66. DOI: https://doi.org/10.1093/sleep/zsab166

Matthews EE, Schmiege SJ, Cook PF, Berger AM, Aloia MS. Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: A pilot study. Behavioral Sleep Med. 2012;10(3):217-29. DOI: https://doi.org/10.1080/15402002.2012.666220

Savard J, Ivers H, Savard M-H, Morin CM. Is a video-based cognitive behavioral therapy for insomnia as efficacious as a professionally administered treatment in breast cancer? Results of a randomized controlled trial. Sleep. 2014;37(8):1305-14. DOI: https://doi.org/10.5665/sleep.3918

Hall DL, Arditte Hall KA, Gorman MJ. The survivorship sleep program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors. Cancer. 2022;128(7):1532-44. DOI: https://doi.org/10.1002/cncr.34066

Wieman ST, Arditte Hall KA, Park ER. Treatment-related changes in insomnia, anticipatory pleasure, and depression symptoms: A proof-of-concept study with cancer survivors. Sleep Med. 2023;103:29-32. DOI: https://doi.org/10.1016/j.sleep.2023.01.011

Haque R, Chlebowski RT, Chen L. Sleep medication uses and risk of fractures in breast cancer survivors. Breast Cancer Res Treat. 2021;190(3):541-8. DOI: https://doi.org/10.1007/s10549-021-06392-4

Tan CJ, Yip SYC, Chan RJ, Chew L, Chan A. Investigating how cancer-related symptoms influence work outcomes among cancer survivors: a systematic review. J Cancer Surv. 2022;16(5):1065-78. DOI: https://doi.org/10.1007/s11764-021-01097-5

Garland SN, Savard J, Dalton K. Rationale and protocol for a randomized waitlist-controlled trial of videoconference delivered cognitive behaviour therapy for insomnia (CBT-I) to improve perceived cognitive impairment (PCI) among cancer survivors. Contemporary Clinical Trials. 2021;103:106322. DOI: https://doi.org/10.1016/j.cct.2021.106322

Li R, Ma Y, Arditte Hall KA. Representation of race and ethnicity among cancer survivors in trials of cognitive behavioral therapy for insomnia (CBT-I): A systematic review. Supportive Care in Cancer. 2024;32(1):23. DOI: https://doi.org/10.1007/s00520-023-08207-2

Zhou ES, Ritterband LM, Bethea TN, Robles YP, Heeren TC, Rosenberg L. Effect of culturally tailored, internet-delivered cognitive behavioral therapy for insomnia in black women: A randomized clinical trial. JAMA psychiatry. 2022;2:56-9. DOI: https://doi.org/10.1001/jamapsychiatry.2022.0653

Edinger JD, Olsen MK, Stechuchak KM, et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: A randomized clinical trial. Sleep. 2009;32(4):499-510. DOI: https://doi.org/10.1093/sleep/32.4.499

Collins L, Murphy S, Nair V, Strecher V. A strategy for optimizing and evaluating behavioral interventions. Annals of Behav Med. 2005;30(1):65-73. DOI: https://doi.org/10.1207/s15324796abm3001_8

Perlis ML, Jungquist C, Smith MT, Posner D. Cognitive behavioral treatment of insomnia: A session-by-session guide. Springer Science & Business Media. 2005;1:29-32.

Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601-8. DOI: https://doi.org/10.1093/sleep/34.5.601

Carney CE, Buysse DJ, Ancoli-Israel S. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep. 2012;35(2):287-302. DOI: https://doi.org/10.5665/sleep.1642

Cella D, Choi SW, Condon DM. PROMIS® adult health profiles: Efficient short-form measures of seven health domains. Value in health. 2019;22(5):537-44. DOI: https://doi.org/10.1016/j.jval.2019.02.004

Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353-65. DOI: https://doi.org/10.2165/00019053-199304050-00006

Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. Research Support, Non-U.S. Gov't. J Cancer Surviv. 2015;9(3):481-91. DOI: https://doi.org/10.1007/s11764-015-0424-4

Taylor DJ, Pruiksma KE. Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: A systematic review. International Rev Psych. 2014;26(2):205-13. DOI: https://doi.org/10.3109/09540261.2014.902808

Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489-95. DOI: https://doi.org/10.1093/sleep/31.4.489

Ye YY, Zhang YF, Chen J. Internet-based cognitive behavioral therapy for insomnia (ICBT-i) improves comorbid anxiety and depression-A meta-analysis of randomized controlled trials. PLoS One. 2015;10(11):142258. DOI: https://doi.org/10.1371/journal.pone.0142258

Irwin MR, Carrillo C, Sadeghi N, Bjurstrom MF, Breen EC, Olmstead R. Prevention of incident and recurrent major depression in older adults with Insomnia: A randomized clinical trial. JAMA Psychiatry. 2022;79(1):33-41. DOI: https://doi.org/10.1001/jamapsychiatry.2021.3422

Blom K, Jernelöv S, Rück C, Lindefors N, Kaldo V. Three-year follow-up comparing cognitive behavioral therapy for depression to cognitive behavioral therapy for insomnia, for patients with both diagnoses. Sleep. 2017;40(8):67. DOI: https://doi.org/10.1093/sleep/zsx108

Downloads

Published

2025-04-28

How to Cite

Balkind, E. G., Willis, K. D., Bolden, C., Muzikansky, A., Gorman, M. J., Comander, A. H., Haggett, D., Wagner, L., Kossowsky, J., Park, E. R., Mukhammadov, T., Adewumi, T., & L. Hall, D. (2025). Innovating CBT-I for cancer survivors: study protocol for a randomized controlled optimization trial. International Journal of Clinical Trials, 12(2), 127–135. https://doi.org/10.18203/2349-3259.ijct20251208